[1] W. BEIL K. Fr S I Hackbarth. Mechanism of gastric antisecretory effect of SCH 28080[J]. British Journal of Pharmacology, 1986, 88 1: 19-23. DOI:
10.1111/j.1476-5381.1986.tb09466.x[2] B WALLMARK. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.[J]. The Journal of Biological Chemistry, 1987, 262 5: 2077-2084.
[3] H G SWARTS. Conformation-dependent inhibition of gastric H+,K+-ATPase by SCH 28080 demonstrated by mutagenesis of glutamic acid 820.[J]. Molecular Pharmacology, 1999, 55 3: 541-547.
[4] JIAHONG SHAO . Pharmacological profiles of the murine gastric and colonic H,K-ATPases[J]. Biochimica et biophysica acta. General subjects, 2010, 1800 9: Pages 906-911. DOI:
10.1016/j.bbagen.2010.05.002[5] WENDY S BEANE. A chemical genetics approach reveals H,K-ATPase-mediated membrane voltage is required for planarian head regeneration.[J]. Chemistry & biology, 2011, 18 1: 77-89. DOI:
10.1016/j.chembiol.2010.11.012[6] SARAH A. SALYER . Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells[J]. Biochimica et biophysica acta. Molecular basis of disease, 2013, 1832 10: Pages 1734-1743. DOI:
10.1016/j.bbadis.2013.04.023